Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children

FABRICIO GARELLI; NICOLÁS ROSALES; EMILIA FUSHIMI; DELFINA ARAMBARRI; LEANDRO MENDOZA; HERNÁN DE BATTISTA; RICARDO SANCHEZ PEÑA; JULIA GARCÍA ARABEHETY; SABRINA DISTEFANO; CONSUELO BARCALA; JAVIER GIUNTA; MARCOS LAS HERAS; CAROLINA MARTINEZ MATEU; MARIANA PRIETO; EDUARDO SAN ROMÁN; GABRIELA KROCHIK; LUIS GROSEMBACHER

DIABETES TECHNOLOGY & THERAPEUTICS

MARY ANN LIEBERT INC

Lugar: New York; Año: 2021

1520-9156

This letter illustrates the potential of a new platform forsimultaneous remote monitoring of multiple intensive careunit (ICU) and/or quarantined patients. To our best knowledge,this is the first multicenter, multisensor, multipatient,and potentially multitherapy platform for remote glucosemonitoring employed in critically ill COVID patients. Wereport the real-time remote monitoring of five COVID-19positive ICU patients, two children and three adults, togetherwith an ambulatory patient to test the platform versatility andlong-term performance. As far as we know, also, this is thefirst multiple ICU monitoring experience, including criticalpediatric COVID positive cases.